Member Info for Elegance

I think it’s volume that counts, trades/buys of 30k and 50k we’re going through, I doubt the MMs are interested in buying stock a tenner at a time.

It should also be noted the immense buying yesterday which far outweighed the sells, at one point it was impossible to buy through HL or TDW. IMO that was MMs loading up buying stock knowing full well there is a rise and possibly news coming next week.

Share price has risen steady this week from the lows of 28p when a new floor was created. IMO we will not see the lows again of 22p as this was only created by the knee jerk action on the day triggering all the stop losses, it would need a piece of very bad press to reproduce this which unlikely to be forth coming. What is likely to be forth coming is some good news about either further trials, a partnerships or a takeover bid based on the fact that more than 10 companies are at this moment looking in to the data of Lupuzor. They wouldn’t be looking at this for nothing, if they can see why nearly 7% of patients went in to remission of Lupus using Lupuzor and standard care then they are going to want to take this forward. It’s very likely that we will test the 40s and even the 50s next week especially if we get some news. Well done to all those that held.

Halfbut our positive outlook and investment is not based on HOPE, it is based on the fact that over 10 pharamacutical companies are currently looking at the data reference Lupuzor, they have all signed nondisclosure agreements and have been extremely positive about Lupuzors outlook. Whilst you are entitled to have your individual negative outlook on here I’m pretty sure the admin need to check your pumping of other stocks and remove your post below. A high of over 100% and a rising price of over 30% increase from the lows of 22p is hardly stagnating. IMO you will see 50p before you see 22p.

Couldn’t buy on HL or TD earlier but some chunky buys now coming through.

GSK paid £9.13 a share for what I believe is the only other notable lupus drug, they chased after the company having initially offered less. I wonder if GSK might offer a take over bid or agree to partner in Lupuzor? More than 10 companies are currently interested in Lupuzor having requested the data from Immupharma after the testing and signed a non disclosure agreement, anyone of them could be making an offer at any time.

..

Needs a signal to break now above 36p/37p and whoosh....

Not sure if any of you follow charts (I am still learning at my ripe old age) but it looks like the band width is narrowing, normally indicates a break out north.

Strongman, lets just say I am confident it was a buy :).... Should be a good finish in to close. I so hope we have a great RNS on the way, would prefer a partner for Lupuzor if I am honest so that Immupharma can carry on with the good work its already done.

Doubtful anyone is selling at this price.

buy at 13:43 showing as a sell.. naughty MM's..

https://business-reporter.co.uk/2017/09/12/stem-cells-treatments-future-healthcare/

Widecell Group > Our ambition is to become the undisputed global leader in stem cell services. We are the first of our kind, pioneers in our field and we aim to be around for a long time.

The Financial Conduct Authority ("the FCA") temporarily suspends the securities set out below from the Official List effective from 3/05/2018 7:30am to """protect investors and maintain the smooth operation of the markets""" As an investor you should be happy this was suspended so that you have minimal loss whilst they sort this out, would you rather it continue down to 1p as shorters pile in? I am invested and glad they temporarily suspended the stock. As has been said, fingers crossed now for a funding and accounts to be filed. Could be days...but at least they have time now to get a good deal rather than be under stress to take anything.

Doesn’t have to be a takeover although that would be amazing! It would be just as good if the RNS said that Immupharma had found a partner to take Lupuzor forward. New ceiling coming up.

Potential is huge! If you watch the video on proactive investors they say that Lupuzor has shown promise towards rheumatoid arthritis and asthma, this will be potentially taken up by a large pharmaceutical. Well done Immupharma!

Last ceiling was 50p building off a floor from 22p, now we have a new floor at 30p could we see a higher ceiling. I do hope for patients as well as investors that Immupharma get a partner to take Lupuzor forward.

https://t.co/dw2q8rBHr6

02-May-18 12:59: 30.0044,020 Sell* 29.8030.30 13.21k